CAS 129311-55-3
:Ganirelix Acetate
Description:
Ganirelix acetate is a synthetic peptide that functions as a gonadotropin-releasing hormone (GnRH) antagonist. It is primarily used in assisted reproductive technology to prevent premature ovulation during controlled ovarian stimulation. The substance is characterized by its ability to competitively inhibit the action of GnRH at the pituitary gland, leading to a decrease in the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This mechanism helps to control the timing of ovulation, thereby enhancing the effectiveness of fertility treatments. Ganirelix acetate is typically administered via subcutaneous injection and is known for its relatively short half-life, necessitating careful dosing and timing in clinical applications. The compound is generally well-tolerated, though some patients may experience side effects such as injection site reactions or hormonal fluctuations. Its chemical structure includes a specific sequence of amino acids, contributing to its biological activity and specificity in targeting GnRH receptors. Overall, Ganirelix acetate plays a crucial role in reproductive medicine, facilitating better outcomes in fertility treatments.
Formula:C84H121ClN18O17
InChI:InChI=1/C80H113ClN18O13.2C2H4O2/c1-9-84-79(85-10-2)88-39-17-15-27-60(70(104)94-62(42-49(5)6)71(105)93-61(28-16-18-40-89-80(86-11-3)87-12-4)78(112)99-41-21-29-68(99)77(111)90-50(7)69(82)103)92-72(106)63(44-53-32-36-58(102)37-33-53)97-76(110)67(48-100)98-74(108)65(45-54-22-20-38-83-47-54)96-73(107)64(43-52-30-34-57(81)35-31-52)95-75(109)66(91-51(8)101)46-56-25-19-24-55-23-13-14-26-59(55)56;2*1-2(3)4/h13-14,19-20,22-26,30-38,47,49-50,60-68,100,102H,9-12,15-18,21,27-29,39-46,48H2,1-8H3,(H2,82,103)(H,90,111)(H,91,101)(H,92,106)(H,93,105)(H,94,104)(H,95,109)(H,96,107)(H,97,110)(H,98,108)(H2,84,85,88)(H2,86,87,89);2*1H3,(H,3,4)/t50-,60-,61+,62+,63+,64-,65-,66-,67+,68+;;/m1../s1
Synonyms:- D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N(sup 6)-((ethylamino)(ethylimino)methyl)-D-lysyl-L-leucyl-N(sup 6)-((ethylamino)(ethylimino)methyl)-L-lysyl-L-prolyl-, diacetate (salt)
- Ganirelix acetate injection
- N-Acetyl-3-(2-naphthyl)-D-alanyl-p-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-N(sup 6)-(N,N'-diethylamidino)-D-lysyl-L-leucyl-N(sup 6)-(N,N'-diethylamidino)-L-lysyl-L-prolyl-D-alaninamide diacetate (salt)
- Unii-56U7906Fqw
- Ganirelix acetate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
D-Alaninamide,N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N6-[bis(ethylamino)methylene]-D-lysyl-L-leucyl-N6-[bis(ethylamino)methylene]-L-lysyl-L-prolyl-, diacetate (salt)
CAS:Formula:C84H121ClN18O17Purity:98%Color and Shape:SolidMolecular weight:1690.4229Ganirelix Trifluoroacetic Acid Salt (>90%)
CAS:Controlled Product<p>Applications Decapeptide LH-RH antagonist. Used in treatment of infertility.<br>References Strickley, R.G., et al.: Pharm. Res., 7, 530 (1990), Jung, G., et al.: J. Med. Chem., 35, 3942 (1992), Rabinovici, J., et al.: J. Clin. Endocrinol. Metab., 75, 1220 (1992), Devroey, P., et al.: Hum. Reprod., 13, 3023 (1998),<br></p>Formula:C80H113ClN18O13•x(C2HF3O2)Purity:>90%Color and Shape:NeatMolecular weight:1570.3211402Ganirelix acetate
CAS:Controlled Product<p>Ganirelix acetate is a synthetic, non-steroidal, anti-hormonal agent of the gonadotropin releasing hormone (GnRH) receptor antagonist class. It is used in research as a building block for fine chemical and pharmaceutical synthesis. Ganirelix acetate has been shown to be useful in the synthesis of drugs that target the GnRH receptor or other receptors with high affinity for GnRH. This compound can act as an intermediate in many chemical reactions and is also a versatile scaffold for drug design.</p>Formula:C80H113ClN18O13•(C2H4O2)2Purity:Min. 95%Color and Shape:White PowderMolecular weight:1,690.42 g/mol
